Dr. Gregory Peter Geba M.D., DR.P.H.
Pulmonologist | Pulmonary Disease
20 York St New Haven CT, 06510About
Dr. Gregory Geba practices Pulmonology in New Haven, CT. A pulmonologist is a physician who possesses specialized knowledge and skill in the diagnosis and treatment of pulmonary conditions and diseases. Dr. Geba manages patients who need life support and mechanical ventilation, and is specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections.
Education and Training
Universidad De Navarra
University Of Navarra 1984
Universidad de Navarra Facultad de Medicina 1984
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.
- Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung.
- Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial.
- Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac
- Cyclooxygenase 2 activity modulates the severity of murine Lyme arthritis.
- Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
- Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
- Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
- Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
- Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the
- The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: a randomized, double-blind clinical trial.
- Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
- Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
- Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
- The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trials.
Dr. Gregory Peter Geba M.D., DR.P.H.'s Practice location
Lake Charles, LA 70605Get Direction
Dr. Gregory Peter Geba M.D., DR.P.H.'s reviews
Write ReviewPatient Experience with Dr. Geba
Recommended Articles
- Former Pro Athlete Sells Medal to Give Teen Soccer Fan Lung Transplant
Mo Johnston, former star athlete as part of both the Rangers and the Celtics has decided he wants to give back. He has decided to sell his league medal in order to raise money so a teen with cystic fibrosis could receive a lung transplant that has become crucial to his health.Background on...
- Stem Cell Therapy Can Reduce Inflammation in Cystic Fibrosis
Cystic fibrosis can cause numerous lung infections that will lead to lung damage and a weaker respiratory system. Scientists have therefore taken to researching different rehabilitation methods on repairing lung damage. There have been a number of recent breakthroughs in lung rehabilitation, but one...
- What Are the Signs and Symptoms of AIDS?
Acquired immunodeficiency syndrome, or AIDS, is a serious secondary immunodeficiency disorder. AIDS is caused by human immunodeficiency virus (HIV). There is progressive destruction of cell-mediated (T cell) immunity. Also, both conditions are characterized by subsequent effects on humoral immunity...
- Cystic Fibrosis: A Day in the Life
Everyday tasks like walking up a set of stairs can be a daunting and debilitating endeavor for individuals with cystic fibrosis. The progressive, lifelong illness causes thick mucus to build up on the inside of critical organs, most notably the lungs. People who live with cystic fibrosis are...
- 47-year-old with Cystic Fibrosis Refuses to Let It Stop Her
Sue Britton, a 47-year-old woman has cystic fibrosis. In her 20s, she became tired of being known and labeled as the ‘sick girl’, so she left her home to embark on a 7-month journey around the world. The fact that she had cystic fibrosis and needed medication on a daily basis did not stop her....
- Is Ibuprofen the Secret to Cystic Fibrosis Treatment?
Scientists say yes. The drug that works wonders for so many other everyday ailments could be a key component in the future treatments of cystic fibrosis patients. It’s hard to imagine that a drug found in nearly everyone's medicine cabinet could be a crucial component in the treatment of cystic...
Nearby Providers
- Dr. Michael Imevbore M.D.46 Prince St New Haven CT 06519
- Dr. Carl B. Sherter MD170 Grandview Avenue Waterbury CT 06708
- Dr. Adil Salam MD15 Corporate Dr Trumbull CT 06611
- Dr. Michael T Vest DO789 Howard Ave New Haven CT 06519
- Dr. Eugene Bunnell MD56 Franklin St Waterbury CT 06706
- Dr. Benjamin Weisman M.D.4699 Main St Bridgeport CT 06606